Iosune Baraibar

1.8k citations
45 papers · 959 · h-index 17

Impact in

  • Oncology top 5%
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers
    • Cancer Genomics and Diagnostics

Papers in

    • Colorectal Cancer Treatments and Studies 27
    • Cancer Immunotherapy and Biomarkers 10
    • Cancer Treatment and Pharmacology 3
    • Lung Cancer Treatments and Mutations 8
    • Gastric Cancer Management and Outcomes 6

Iosune Baraibar

37 papers receiving 946 citations

Peers

Iosune Baraibar
Comparison fields: 5 of 71
  • Oncology 495
  • Cancer Research 182
  • Pathology and Forensic Medicine 173
  • Pulmonary and Respiratory Medicine 236
  • Molecular Biology 284
Replace Dana B. Cardin with:
Dana B. Cardin United States
Marisol Huerta Spain
Kalliopi Andrikou Italy
Benjamin A. Weinberg United States
Alba Dalmases Spain
Guoshuang Shen China
Loredana Vecchione Italy
Fraser Symmans United States
Marta Bonotto Italy
Ramon Andrade de Mello Portugal
Iosune Baraibar relative to Dana B. Cardin United States Dana B. Cardin's profile →
Citations per field
00.5×1.5×1.8×
Dana B. Cardin · 1×
Citations per year

Countries citing papers authored by Iosune Baraibar

Since Specialization
Citations

This map shows the geographic impact of Iosune Baraibar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iosune Baraibar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iosune Baraibar more than expected).

Fields of papers citing papers by Iosune Baraibar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iosune Baraibar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iosune Baraibar. The network helps show where Iosune Baraibar may publish in the future.

Co-authors

The 25 scholars most cited alongside Iosune Baraibar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iosune Baraibar Line = papers co-authored together Iosune Baraibar links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2018233
2 201981
3 202352
4 202149
5 202148
6 202048
7 202143
8 202340
9 202036
10 202334
11 201731
12 202329
13 202326
14 202423
15 202422
16 201119
17 202318
18 202115
19 202013
20 202311

About Iosune Baraibar

Iosune Baraibar is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Cancer Research and Molecular Biology, having authored 45 papers that have together received 959 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (27 papers), Genetic factors in colorectal cancer (12 papers), Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (6 papers), Gastric Cancer Management and Outcomes (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Oncology (495 citations), Cancer Research (182 citations), Pathology and Forensic Medicine (173 citations), Pulmonary and Respiratory Medicine (236 citations) and Molecular Biology (284 citations). Iosune Baraibar has collaborated with scholars based in Spain, Italy and Belgium. Frequent co-authors include Javier Ros, Elena Élez, Josep Tabernero, Francesc Salvà, Ignacio Gil‐Bazo, Marta Román, Christian Rolfo, Inés López, Ernest Nadal and Silvestre Vicent. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Annals of Oncology, Therapeutic Advances in Medical Oncology and Expert Opinion on Investigational Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact